Education
About Us
Working with TipRanks
Follow Us
Vectus Biosystems Limited (AU:VBS)
ASX:VBS
RESEARCH TOOLSreports
Total Valuation
Vectus Biosystems Limited has a market cap or net worth of AU$2.93M. The enterprise value is AU$1.16M.
Market CapAU$2.93M
Enterprise ValueAU$1.16M
Share Statistics
Vectus Biosystems Limited has 53,333,332 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,333,332
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vectus Biosystems Limited’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -102.76%.
Return on Equity (ROE)-1.57
Return on Assets (ROA)-1.15
Return on Invested Capital (ROIC)-102.76%
Return on Capital Employed (ROCE)-1.52
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.56
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio4.88
Price to Fair Value2.72
Price to FCF-1.40
Price to Operating Cash Flow-1.37
PEG Ratio-0.26
Income Statement
In the last 12 months, Vectus Biosystems Limited had revenue of 1.14M and earned -2.34M in profits. Earnings per share was -0.04.
Revenue1.14M
Gross Profit1.14M
Operating Income-2.27M
Pretax Income-3.40M
Net Income-2.34M
EBITDA-2.27M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -1.44M and capital expenditures 27.01K, giving a free cash flow of -1.41M billion.
Operating Cash Flow-1.44M
Free Cash Flow-1.41M
Free Cash Flow per Share-0.03
Dividends & Yields
Vectus Biosystems Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.52
52-Week Price Change-40.00%
50-Day Moving Average0.05
200-Day Moving Average0.07
Relative Strength Index (RSI)82.50
Average Volume (3m)36.85K
Important Dates
Vectus Biosystems Limited upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateFeb 21, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Vectus Biosystems Limited as a current ratio of 3.45, with Debt / Equity ratio of 0.00%
Current Ratio3.45
Quick Ratio3.45
Debt to Market Cap0.00
Net Debt to EBITDA0.34
Interest Coverage Ratio-260.87
Taxes
In the past 12 months, Vectus Biosystems Limited has paid -1.06M in taxes.
Income Tax-1.06M
Effective Tax Rate0.31
Enterprise Valuation
Vectus Biosystems Limited EV to EBITDA ratio is -1.44, with an EV/FCF ratio of -1.55.
EV to Sales2.87
EV to EBITDA-1.44
EV to Free Cash Flow-1.55
EV to Operating Cash Flow-1.61
Balance Sheet
Vectus Biosystems Limited has AU$809.89K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$809.89K billion.
Cash & Marketable SecuritiesAU$809.89K
Total DebtAU$0.00
Net Cash-AU$809.89K
Net Cash Per Share-AU$0.02
Tangible Book Value Per ShareAU$0.03
Margins
Gross margin is 100.00%, with operating margin of -199.41%, and net profit margin of -205.34%.
Gross Margin100.00%
Operating Margin-199.41%
Pretax Margin-298.51%
Net Profit Margin-205.34%
EBITDA Margin-199.41%
EBIT Margin-204.57%
Analyst Forecast
The average price target for Vectus Biosystems Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target―
Price Target Upside―
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast9.19%